CB50430-21 - 0x000000000000721F
Males & Females of Non-Childbearing Potential
Raindrop
* Stipend may pay up to reflected amount.
Start Date:
October 8, 2026 - 10:00am
End Date:
October 27, 2026 - 9:30am
Study Details
Study Number: CB50430
Group Number: 21
Study Requirement: Healthy Normal Male and Female
Stipend: up to $3,250.00
Study Criteria
Age: 18 - 55
BMI: 18 - 30
Weight Restriction: minimum weight 111 lbs
Study Information
Indication: This investigational medication is being developed to treat cancer.
Route of Administration: Oral
Blood Draws: 30
Study Schedule
Schedule Type: Short Term
Study Length: 5 Night Stay & 1 Phone Call
Screening Dates:
| Event Day | Event Date |
|---|---|
| Wednesday | 9/30/2026 |
Doctor Exam Dates:
| Event Day | Event Date |
|---|---|
| Wednesday | 9/30/2026 |
Study Dates:
| Event Type | Start Day | Start Date | End Day | End Date | Phase | Site |
|---|---|---|---|---|---|---|
| Check-In | Thursday | 10/8/2026 10:00:00 AM | Tuesday | 10/13/2026 7:00:00 PM | 1 | Phoenix |
| Phone participant | Tuesday | 10/27/2026 9:30:00 AM | 1 | Phoenix |
